Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-662-7750
Dr. Farwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Nuclear Radiology, 2012 - 2013- New York Presbyterian Hospital (Columbia Campus)Residency, Radiology-Diagnostic, 2008 - 2012
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2007 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2007
Certifications & Licensure
PA State Medical License 2013 - 2026
NJ State Medical License 2014 - 2025
NY State Medical License 2008 - 2013
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- [F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancer.Sarah B Gitto, Austin R Pantel, Kara N Maxwell, Daniel A Pryma, Michael D Farwell
Communications Medicine. 2025-03-25 - A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points.Swarbhanu Sarkar, Jonathan M Pham, Kimberly J Edwards, Nitika Sharma, Kexiang Xu
EJNMMI Research. 2025-03-24 - MRS and Optical Imaging Studies of Therapeutic Response to Combination Therapy Targeting BRAF/MEK in Murine Melanomas.Pradeep Kumar Gupta, Lin Z Li, Dinesh Kumar Singh, Skyler Nova, Fernando Arias-Mendoza
Academic Radiology. 2025-02-20
Press Mentions
Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research GrantsApril 3rd, 2017
FDG PET/CT Imaging After Just One Week May Predict Treatment Response in Patients with Advanced MelanomaJanuary 24th, 2024- Imaging Just One Week After Starting Treatment Can Predict Melanoma Response to ImmunotherapyJanuary 25th, 2024
Grant Support
- Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumor treatmentUNIVERSITY OF PENNSYLVANIA2024–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
